In a recent study published in Scientific Reports, researchers investigated whether trypsin, a protease, increased severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity. In addition ...

Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed a worldwide threat. The emergence of the BA.2.86 variant, a subvariant of Omicron, has raised significant ...

Scientists at UCSF QBI, University College London and the Icahn School of Medicine at Mount Sinai reported breakthrough findings in a study published Sept. 21, 2023, on convergent evolutionary ...

Researchers from Japan findings indicate that JN.1 has a higher ability to spread than some prevalent variants like BA.2.86.1 and HK.3, potentially making it the dominant strain globally. Since ...

OBJECTIVESTo evaluate the effectiveness of the mRNA-1273 vaccine against SARS-CoV-2 variants and assess its effectiveness against the delta variant by time since vaccination. DESIGNTest negative ...

After exhausting years of the pandemic with multiple waves of infections caused by ever-changing virus variants and corresponding hospitalization rates, the situation has significantly improved by now ...

Scientists decipher how the antibody response of our immune system reacts to a coronavirus infection and prepares for future infections. Although SARS-CoV-2 is no longer a stranger to the immune ...

A new variant of the virus that causes COVID-19 is rising to prominence in the U.S. as winter illness season approaches its peak: JN.1, yet another descendent of Omicron. JN.1 was first detected in ...

Covid has largely dropped out of the headlines, but the virus that causes it is still circulating. We ask what we should know about a new variant of SARS-CoV-2, the state of the Covid pandemic in 2025 ...

Exevir Bio BV has demonstrated that its antibodies are potent in neutralizing the SARS-CoV-2 variant JN.1, the parental strain of the currently most dominantly circulating variants worldwide.